drugset / Trial / NCT02066844
Navigator vs Standard Needle Injection for Hip
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this randomized, parallel-group, single-blinded, single center, Phase II study is to collect data to compare the comfort and patient satisfaction of a hip injection delivered via the Navigator compared to a standard needle injection. In addition, delivery preparation will be compared between a Navigator injection and a standard hip injection. The data collected from this pilot study will serve as the basis to design a larger multi-center study.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Betamethasone | Other / unclassified | 2 ml | — |
| Background | Lidocaine | Other / unclassified | 5 ml | — |